Article

Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease - Down…

medRxiv · 2023 · Wu, Y.; Mumford, P.; Noy, S.; Cleverley, K.; Mrzyglod, A.; Luo, D.; Dalen, F. v.; Verdoes, M.; Fisher, E. M. C.; Wiseman, F. K.

Key facts

Title Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease - Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin B
First author Wu, Y.; Mumford, P.; Noy, S.; Cleverley, K.; Mrzyglod, A.; Luo, D.; Dalen, F. v.; Verdoes, M.; Fisher, E. M. C.; Wiseman, F. K.
Journal medRxiv
Published Jun 23, 2023
DOI 10.1101/2023.06.20.545700
Devices mentioned K800552, K810863, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840, K920529, K920967 and 11 more
Product codes mentioned DBM, EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, KKX

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature